Tr1x, Inc.
Clinical trials sponsored by Tr1x, Inc., explained in plain language.
-
New cell therapy TRX319 aims to slow progressive MS
Disease control Recruiting nowThis early-stage trial tests TRX319, a cell therapy, in 39 adults with primary or secondary progressive MS. The goal is to see if it is safe, find the best dose, and check if pre-treatment with another drug helps it work. Participants receive up to 3 doses over a year and undergo…
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New cell therapy TRX103 aims to tame stubborn Crohn's disease
Disease control Recruiting nowThis study tests a new treatment called TRX103 for people with moderate to severe Crohn's disease that hasn't improved with other treatments. The goal is to see if TRX103 is safe and can help control the disease. About 39 adults aged 18 to 65 will receive different doses of TRX10…
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC